- Medical School - University of Minnesota (2006-2010)
- Residency - Washington University in St. Louis School of Medicine (2010-2015), Otolaryngology
- Graduate School - Johns Hopkins Bloomberg School of Public Health (2016-2017), Public Health
- Fellowship - Johns Hopkins Hospital (2015-2017), Head & Neck Oncology Surgery and Microvascular Reconstructi
Andrew Day, M.D.
- Eugene P. Frenkel, M.D. Scholar in Clinical Medicine
- Head & Neck Cancers
- Oral & Throat (Pharyngeal) Disorders
Andrew T. Day, M.D., M.P.H., is an Assistant Professor of Otolaryngology – Head and Neck Surgery at UT Southwestern Medical Center. He is also a member of the Population Science and Cancer Control program at the Harold C. Simmons Comprehensive Cancer Center.
Dr. Day earned his medical degree at the University of Minnesota Medical School. Following his residency in Otolaryngology – Head and Neck Surgery at Washington University in St Louis School of Medicine, he received advanced training in Head and Neck Oncologic Surgery and Microvascular Reconstruction at Johns Hopkins University School of Medicine. He then earned a Master of Public Health degree from the Johns Hopkins Bloomberg School of Public Health.
His clinical interests primarily include the management of benign and malignant tumors of the head and neck. He has specific expertise in complex ablative surgery, transoral laser microsurgery (TLM), transoral robotic surgery (TORS), reconstructive surgery, open and minimally-invasive salivary gland surgery, and thyroid and parathyroid surgery.
Dr. Day has published in a number of journals and serves as an ad-hoc reviewer for Oral Oncology, Head Neck, and JAMA Otolaryngology – Head and Neck Surgery. His research interests include early detection of head and neck cancer, improving the quality of life and survival of cancer survivors, and head and neck cancer outcomes.
He is a member of several professional organizations, including the American Head and Neck Society, the American Academy of Otolaryngology – Head and Neck Surgery, and the Triological Society.
In 2019 and 2020, Dr. Day was named a Texas Monthly Super Doctor Rising Star.
Meet Dr. Day
Life after a head and neck cancer diagnosis is hard enough. Struggling to navigate head and neck cancer care after a diagnosis can make life even harder. The head and neck cancer team at UT Southwestern wants to help patients avoid this experience.
“We partner with patients in their journey
towards long-term head and neck cancer survivorship,” says Andrew T. Day, M.D., M.P.H., a head and neck cancer and reconstructive surgeon at UT Southwestern.
There are often multiple treatment options for patients with head and neck cancer, and each option has a unique side-effect profile with different risks and benefits. “This decision-making process can be confusing and challenging for patients, especially because sometimes there isn’t a ‘right’ answer,” says Dr. Day. “We provide patients with the best available evidence and support them in their decision-making process. We want to empower patients to make the best treatment choice for them.”
At UT Southwestern, patients receive advanced, multidisciplinary head and neck cancer care. The team includes seven fellowship-trained head and neck cancer and reconstructive surgeons, three radiation oncologists, and two medical oncologists, as well as other facial plastic and reconstructive surgeons, pathologists, neuroradiologists, dentists, speech and language pathologists, nurse specialists, nurse navigators, dietitians, clinical trialists, clinical and basic science researchers, and administrative staff.
“We’ve all dedicated our careers to help patients with head and neck cancer. Everyone contributes and we work together. We’re proud of what we have here.” Each patient is discussed at the multidisciplinary tumor board where everyone has an opportunity to provide input. “Then we share the results of the discussion with our patients,” says Dr. Day.
The head and neck cancer team at UT Southwestern is also at the cutting edge of clinical care and research. “In the last fifteen years, head and neck cancer care in the U.S. has evolved significantly,” says Dr. Day.
Different types of head and neck cancer were discovered. Transoral robotic surgery was pioneered and popularized. The concept of treatment “de-intensification” is now widely studied. Additionally, immunotherapy has recently been shown to prolong survival in select head and neck cancer patients.
“Members of our group have been at the frontline of many of these advances," Dr. Day says. "We fail our patients if we don’t provide access to the best available treatments in surgery, radiation, medical oncology, and immunology.”
In addition to traditional cancer resections and other head and neck procedures, Dr. Day performs minimally-invasive transoral laser microsurgery and transoral robotic surgery. He also performs complex reconstructive surgery for patients with head and neck cancer defects. His research focuses on health outcomes of head and neck cancer patients, early detection of head and neck cancer, and improving quality of life and survival in head and neck cancer survivors.
- Texas Monthly Super Doctors, Rising Star 2020
- Texas Monthly Super Doctors, Rising Star 2019
Regional flaps in Facial Plastic and Reconstructive Surgery: Clinical Reference Guide
Day AT, Chaudhary HA, Richmon JD. (2016), San Diego, Plural Publishing, Inc.
Radioiodine sialadenitis in Gland-Preserving Salivary Surgery ? A Problem-Based Approach
Day AT, Eisele DW. (2017), Berlin, Springer
- Regional flaps in Facial Plastic and Reconstructive Surgery: Clinical Reference Guide
Commercial Claims-Based Comparison of Survival and Toxic Effects of Definitive Radiotherapy vs Primary Surgery in Patients With Oropharyngeal Squamous Cell Carcinoma.
Sher DJ, Agiro A, Zhou S, Day AT, DeVries A JAMA otolaryngology-- head & neck surgery 2018 Oct 144 10 913-922
Otolaryngology resident experience with supraclavicular, submental and other regional flaps in the United States.
Day AT, Tang L, Patel UA, Richmon JD, Emerick KS American journal of otolaryngology 2018 May
Impact of high- versus low-risk genotype on sinonasal radiographic disease in cystic fibrosis.
Halderman AA, Lee S, London NR, Day A, Jain R, Moore JA, Lin SY The Laryngoscope 2018 Dec
Supraclavicular flap practice patterns and outcomes: A survey of 221 AHNS surgeons.
Day AT, Tang L, Emerick K, Patel UA, Deschler DG, Richmon JD The Laryngoscope 2018 Dec
Comparative effectiveness of primary radiotherapy versus surgery in elderly patients with locally advanced oropharyngeal squamous cell carcinoma
Sher DJ, Yan J, Day A, Sumer BD, Pham N, Khan S, Zhu H. Oral oncology. 2018
Soft Palate Reconstruction: An Algorithmic Approach and Review
Britt CJ, Hwang MH, Day AT, Boahene K, Byrne P, Haughey BH, Desai SC. JAMA facial plastic surgery. 2018
Tobacco treatment programs at National Cancer Institute-designated cancer centers: a systematic review and online audit
Day AT, Tang L, Karam-Hage M, Fahkry C. American journal of clinical oncology. 2018
Surgical Fires in Otolaryngology: A Systematic and Narrative Review.
Day AT, Rivera E, Farlow JL, Gourin CG, Nussenbaum B Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 2018 Jan 194599817746926
Development and external validation of a risk-prediction model to predict 5-year overall survival in advanced larynx cancer.
Petersen JF, Stuiver MM, Timmermans AJ, Chen A, Zhang H, O'Neill JP, Deady S, Vander Poorten V, Meulemans J, Wennerberg J, Skroder C, Day AT, Koch W, van den Brekel MWM The Laryngoscope 2017 Nov
Salvage arterial anastomosis using a microvascular coupler in head and neck free flap reconstruction.
Genther DJ, Day AT, Rana K, Richmon JD The Laryngoscope 2017 Mar 127 3 642-644
Management of primary T1-T4 glottic squamous cell carcinoma by transoral laser microsurgery.
Day AT, Sinha P, Nussenbaum B, Kallogjeri D, Haughey BH The Laryngoscope 2017 Mar 127 3 597-604
The robotic ENT microsurgery system: A novel robotic platform for microvascular surgery.
Feng AL, Razavi CR, Lakshminarayanan P, Ashai Z, Olds K, Balicki M, Gooi Z, Day AT, Taylor RH, Richmon JD The Laryngoscope 2017 Jun
Treatment, short-term outcomes, and costs associated with larynx cancer care in commercially insured patients.
Day AT, Chang HY, Quon H, Kang H, Kiess AP, Eisele DW, Frick KD, Gourin CG The Laryngoscope 2017 Jul
Successful facial artery pseudoaneurysm coiling and pedicle preservation following free tissue transfer.
Day AT, Genther DJ, Hui F, Mydlarz WK, Griffith G, Desai SC American journal of otolaryngology 2017 Jan - Feb 38 1 103-107
Transoral robotic thyroidectomy: a preclinical feasibility study using the da Vinci Xi platform.
Russell JO, Noureldine SI, Al Khadem MG, Chaudhary HA, Day AT, Kim HY, Tufano RP, Richmon JD Journal of robotic surgery 2017 Feb
Prevertebral muscle flap for internal carotid artery coverage during oropharyngeal transoral surgery.
Day AT, Haughey BH, Rich JT The Laryngoscope 2017 Apr
Transoral robotic thyroidectomy
Richmon JD, Tufano RP, Russell J, Day A, Chaudhary HA, Noureldine SI VideoEndocrinology 2016 3 4
Early Practice: External Sinus Surgery and Procedures and Complications.
Schneider JS, Day A, Clavenna M, Russell PT, Duncavage J Otolaryngologic clinics of North America 2015 Oct 48 5 839-50
Severe nasal frostbite injury from nasal cannula supplemental oxygen malfunction.
Jabbour N, Heman-Ackah SE, Day AT, Odland R American journal of otolaryngology 2011 Jul-Aug 32 4 349-52
- Commercial Claims-Based Comparison of Survival and Toxic Effects of Definitive Radiotherapy vs Primary Surgery in Patients With Oropharyngeal Squamous Cell Carcinoma.
- Head & Neck Cancers
- Oral & Throat (Pharyngeal) Disorders
- Surgical Treatment of Head & Neck Cancers
- Oral & Throat Surgeries
- Surgical Treatment of Benign Head & Neck Conditions
- Skull Based Surgery
- Skin Cancer Reconstruction
- Head & Neck Reconstructive Surgery
- Treatment of Neurofibromatosis
- Soft Tissue Sarcoma
- Parathyroid & Thyroid Conditions
- Nose & Sinus Surgery
- Nasal Problems